Abstract
R. Gary Sibbald, Elizabeth A. Ayello, Dale Kalina Samji, Cathryn J. Sibbald
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
10.1111/jdv.20472 · 2025
Wound Bed Preparation 2021
10.1097/01.asw.0000733724.87630.d6 · 2021
Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 study
10.1016/j.jaad.2025.10.149 · 2026
Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 study
10.1016/j.jaad.2025.10.149 · doi-reference
Wound Bed Preparation 2021
10.1097/01.asw.0000733724.87630.d6 · doi-reference
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
10.1111/jdv.20472 · doi-reference